Details of the Drug Pharmacogenomic Perturbation Atlas
General Information of Drug (ID: DMU6FOG)
| Drug Name | ||||||
|---|---|---|---|---|---|---|
| Synonyms |
CLORSULON; 60200-06-8; Curatrem; Clorsulonum [Latin]; Clorsulone [French]; Clorsulon [Spanish]; UNII-EG1ZDO6LRD; EG1ZDO6LRD; EINECS 262-100-2; MK 401; MK-401; BRN 2821757; 4-amino-6-(1,2,2-trichloroethenyl)benzene-1,3-disulfonamide; 4-Amino-6-(trichlorovinyl)-m-benzenedisulfonamide; L 631529; L-631,529; 4-Amino-6-(trichlorovinyl)-1,3-benzenedisulfonamide; 4-Amino-6-(trichloroethenyl)-1,3-benzenedisulfonamide; 1,3-Benzenedisulfonamide, 4-amino-6-(trichloroethenyl)-; NCGC00016893-01; NCGC00182084-01
| |||||
| Cross-matching ID | ||||||
Consensus Signature of Drug Pharmacogenomic Perturbation (DPP)
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Pharmacogenomic Perturbation Across Diseases and Tissues
|
Breast
Breast adenocarcinoma
Prostate
Prostate carcinoma
|
||||||||||||||||||||||||||||||||||||||||||
